[1] Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit[J]. Crit Care Med, 2006, 34(3):857-863.
[2] Montagna MT, Lovero G, De Giglio O, et al. Invasive fungal infections in neonatal intensive care units of Southern Italy:a multicentre regional active surveillance (AURORA project)[J]. J Prev Med Hyg, 2010, 51(3):125-130.
[3] Leon C, Ruiz-Santana S, Saavedra P, et al. A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization[J]. Crit Care Med, 2006, 34(3):730-737.
[4] 吉凯强,臧彬.侵袭性念珠菌病的诊治[J]. 实用药物与临床. 2009,12(5):305- 307.
[5] Montagna MT, Coretti C, Lovero G, et al. Diagnostic performance of 1——>3-beta-d-glucan in neonatal and pediatric patients with candidemia[J]. Int J Mol Sci, 2011, 12(9):5871-5877.
[6] Awasthi AK, Jain A, Awasthi S, et al. Epidemiology and microbiology of nosocomial pediatric candidemia at a Northern Indian Tertiary Care Hospital[J].Mycopathologia, 2011, 172(4):269-277.
[7] Yang ZT, Wu L, Liu XY, et al. Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in Shanghai[J]. BMC infectious diseases, 2014, 14(1):241.
[8] Cleveland AA, Farley MM, Harrison LH, et al. Changes in incidence and antifungal drug resistance in candidemia:results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011[J]. Clin Infect Dis, 2012, 55(10):1352-1361.
[9] Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals:analysis of 24,179 cases from a prospective nationwide surveillance study[J]. Clin Infect Dis, 2004, 39(3):309-317.
[10] Kindo A, Giri S. A review of Candida species causing blood stream infection[J]. Indian J Med Microbiol, 2012, 30(3):270.
[11] Kocmanová I, Lysková P, Chrenkova V, et al. Nosocomial candidemia in the Czech Republic in 2012-2015:results of a microbiological multicentre study[J]. Epidemiol Mikrobiol Imunol, 2018, 67(1):3-10.
[12] Bassetti M, Taramasso L, Nicco E, et al. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy[J]. PLoS One, 2011, 6(9):e24198.
[13] 刘晓颖, 吴霖, 陈影, 等. 酵母菌血症流行病学及影响近期病死率的危险因素分析[J]. 微生物与感染, 2013, 8(4):234-243.
[14] Lin MY,Carmeli Y, Zumsteg J, et al. Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia:a case-case-control study[J]. Antimicrob Agents Chemother, 2005, 49(11):4555-4560.
[15] Clark TA,Slavinski SA, Morgan J, et al. Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital[J] J Clin Microbiol, 2004, 42(10):4468-4472.
[16] Komshian SV, Uwaydah AK, Sobel JD, et al. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient:frequency, characteristics, and evaluation of factors influencing outcome[J]. Rev Infect Dis, 1989, 11(3):379-390.
[17] 刘自贵, 裘雁秋, 谭明珍,等. 院内念珠菌感染及其药物敏感性研究[J]. 中华医院感染学杂志, 2000, 10(4):304-305.
[18] 刘永碧, 马厚勋. 深部念珠菌感染280例临床分析[J]. 中华医院感染学杂志, 1998, 8(1):31-32.
[19] Merz WG. Candidalusitaniae:frequency of recovery, colonization, infection, and amphotericin B resistance[J]. J Clin Microbiol, 1984, 20(6):1194-1195.
[20] Leon C, Ruiz-Santana S, Saavedra P, et al. Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients:a prospective multicenter study[J].Crit Care Med, 2009, 37(5):1624-1633.
[21] Blumberg HM, Jarvis WR,Soucie JM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients:the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey[J]. Clin Infect Dis,2001, 33(2):177-186.
[22] Mahieu LM, Van Gasse N, Wildemeersch D, et al. Number of sites of perinatal colonization and neutropenia are associated with nosocomial candidemia in the neonatal intensive care unit patient[J]. Pediatr Crit Care Med, 2010, 11(2):240-245.
[23] León C, Ruiz-Santana S, Saavedra P, et al. A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with colonization[J].Crit Care Med, 2006, 34(3):730-737.
[24] Leroy G,Lambiotte F, Thévenin D, et al. Evaluation of "Candida score" in critically ill patients:a prospective, multicenter, observational, cohort study[J]. Ann Intensive Care, 2011, 1(1):50.
[25] Magill SS, Swoboda SM, Johnson EA, et al. The association between anatomic site of colonization, invasive candidiasis, and mortality in critically ill surgical patients[J]. Diagn Microbiol Infect Dis, 2006, 55(4):293-301.
[26] Charles PE, Dalle F, Aube H, et al. Candida spp. colonization significance in critically ill medical patients:a prospective study[J]. Intensive Care Med, 2005, 31(3):393-400.
[27] Lau AF, Kabir M, Chen SC, et al. Candida colonization as a risk marker for invasive candidiasis in mixed medical-surgical intensive care units:development and evaluation of a simple, standard protocol[J]. J Clin Microbiol, 2015, 53(4):1324-1330.
[28] 李贞.不同部位念珠菌的定植和侵袭性念珠菌感染发生的相关性研究[D].上海:上海交通大学,2016.
[29] Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis[J]. Microbiol Mol Biol Rev, 2003, 67(3):400-428.
[30] Shin JH, Kee SJ, Shin MG, et al. Biofilm production by isolates of species recovered from nonneutropenic patients:comparison of bloodstream isolates with isolates from other sources[J].J Clin Microbiol, 2002, 40(4):1244-1248.
[31] Pannanusorn S, Fernandez V, Römling U. Prevalence of biofilm formation in clinical isolates of Candida species causing bloodstream infection[J]. Mycoses, 2013, 56(3):264-272.
[32] Munoz P, Giannella M, Fanciulli C, et al. Candida tropicalis fungaemia:incidence, risk factors and mortality in a general hospital[J]. Clin Microbiol Infect, 2011, 17(10):1538-1545.
[33] Lipsett PA. Surgical critical care:fungal infections in surgical patients[J].Crit Care Med, 2006, 34(9):S215-S224.
[34] Pittet D, Monod M, Suter PM, et al. Candida colonization and subsequent infections in critically ill surgical patients[J]. Ann Surg, 1994, 220(6):751.
[35] 王晨, 李贞, 何羽童, 等. 定植指数对于监测EICU患者发生侵袭性假丝酵母菌感染的临床意义[J].上海交通大学学报:医学版, 2016, 36(11):1605-1609.
[36] Piarroux R, Grenouillet F, Balvay P, et al. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients[J]. Crit Care Med, 2004, 32(12):2443-2449.
[37] Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients[J]. Lancet Infect Dis, 2003, 3(11):685-702.
[38] 夏睿, 王东浩, 李丁, 等. 校正定植指数在肿瘤重症患者侵袭性念珠菌感染抢先治疗中的应用[J]. 山东医药, 2010, 50(44):77-78.
[39] 王东浩, 高心晶, 魏路清,等. 校正念珠菌定植指数在重症侵袭性念珠菌感染抢先治疗中的应用——多中心前瞻性随机对照临床研究[J]. 中国危重病急救医学, 2009, 21(9):118.